Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160257210> ?p ?o ?g. }
- W2160257210 endingPage "S89" @default.
- W2160257210 startingPage "S83" @default.
- W2160257210 abstract "Endothelin-1 (ET-1) is a powerful vasoconstrictor peptide and regulator of blood flow that plays an important role in blood pressure (BP) elevation in some models of experimental hypertension such as DOCA-salt rat, DOCA-salt-treated spontaneously hypertensive rats (SHR), stroke-prone SHR, Dahl salt-sensitive rats, angiotensin II-infused rats, and one-kidney, one-clip Goldblatt rats, but not in SHR, two-kidney, one-clip hypertensive rats, transgenic (mREN2)27 rats, or Nω-nitro-L-arginine methyl ester chronically treated rats. In those models of hypertension in which ET-1 plays a vasoconstrictor role, ET-1 was shown to be overexpressed in the vessel walls, or BP has been lowered by administration of ETA/B- and ETA-selective receptor antagonists. In these experimental models, endothelin receptor antagonists also regressed vascular growth and inflammation, and improved endothelial dysfunction. Hypertensive rats treated with endothelin antagonists were protected from stroke and renal injury. In hypertensive rats without generalized vascular overproduction of ET-1, expression of ET-1 was often enhanced in intramyocardial coronary arteries, suggesting a role of ET in myocardial ischemia in hypertension. Moderate-to-severe hypertensive patients presented enhanced expression of preproET-1 mRNA in the endothelium of subcutaneous resistance arteries, suggesting that this stage of hypertension may respond particularly well to endothelin antagonism. In some hypertensive patients, exaggerated vascular responses to ET-1 were found. Hypertensive patients with coronary artery disease have increased arterial expression of ET-1. Increased plasma levels of immunoreactive ET have been described in African Americans. ET-1 plays an important role in atherosclerosis, for which hypertension is an important risk factor, and in ischemic heart disease and stroke. Endothelin-1 may also be involved in other forms of vascular disease, including pulmonary hypertension, after angioplasty restenosis, after allograft vasculopathy, and vasculitis. Thus, ET-1 may participate in vascular damage in cardiovascular disease and in BP elevation in experimental models and in human hypertension. Endothelin antagonists could become effective disease-modifying agents in different forms of cardiovascular disease. Am J Hypertens 2001;14:83S–89S © 2001 American Journal of Hypertension, Ltd." @default.
- W2160257210 created "2016-06-24" @default.
- W2160257210 creator A5046910928 @default.
- W2160257210 date "2001-11-01" @default.
- W2160257210 modified "2023-10-16" @default.
- W2160257210 title "Role of endothelin-1 in hypertension and vascular disease" @default.
- W2160257210 cites W1929084030 @default.
- W2160257210 cites W193624571 @default.
- W2160257210 cites W1954329710 @default.
- W2160257210 cites W1972252772 @default.
- W2160257210 cites W1972565751 @default.
- W2160257210 cites W1974904913 @default.
- W2160257210 cites W1980347881 @default.
- W2160257210 cites W1990134809 @default.
- W2160257210 cites W1991119019 @default.
- W2160257210 cites W1997310239 @default.
- W2160257210 cites W1999144667 @default.
- W2160257210 cites W2000004245 @default.
- W2160257210 cites W2001899532 @default.
- W2160257210 cites W2002333689 @default.
- W2160257210 cites W2008024908 @default.
- W2160257210 cites W2011048840 @default.
- W2160257210 cites W2013230926 @default.
- W2160257210 cites W2013616551 @default.
- W2160257210 cites W2014578041 @default.
- W2160257210 cites W2015582757 @default.
- W2160257210 cites W2019472350 @default.
- W2160257210 cites W2020741324 @default.
- W2160257210 cites W2023578446 @default.
- W2160257210 cites W2029171451 @default.
- W2160257210 cites W2029969503 @default.
- W2160257210 cites W2041636354 @default.
- W2160257210 cites W2043454729 @default.
- W2160257210 cites W2050071705 @default.
- W2160257210 cites W2050185025 @default.
- W2160257210 cites W2051285665 @default.
- W2160257210 cites W2055473436 @default.
- W2160257210 cites W2056966654 @default.
- W2160257210 cites W2058799403 @default.
- W2160257210 cites W2059369537 @default.
- W2160257210 cites W2063283873 @default.
- W2160257210 cites W2064233057 @default.
- W2160257210 cites W2069377429 @default.
- W2160257210 cites W2072061985 @default.
- W2160257210 cites W2080422687 @default.
- W2160257210 cites W2085838621 @default.
- W2160257210 cites W2087590866 @default.
- W2160257210 cites W2088505113 @default.
- W2160257210 cites W2089500756 @default.
- W2160257210 cites W2091581734 @default.
- W2160257210 cites W2092013456 @default.
- W2160257210 cites W2093571860 @default.
- W2160257210 cites W2097501580 @default.
- W2160257210 cites W2097539092 @default.
- W2160257210 cites W2098055944 @default.
- W2160257210 cites W2104840130 @default.
- W2160257210 cites W2105763003 @default.
- W2160257210 cites W2109591901 @default.
- W2160257210 cites W2114609348 @default.
- W2160257210 cites W2114778001 @default.
- W2160257210 cites W2128005995 @default.
- W2160257210 cites W2134063936 @default.
- W2160257210 cites W2136372976 @default.
- W2160257210 cites W2144935053 @default.
- W2160257210 cites W2146046550 @default.
- W2160257210 cites W2146098757 @default.
- W2160257210 cites W2150612536 @default.
- W2160257210 cites W2151869895 @default.
- W2160257210 cites W2152097865 @default.
- W2160257210 cites W2156281812 @default.
- W2160257210 cites W2159279848 @default.
- W2160257210 cites W2161240048 @default.
- W2160257210 cites W2162804111 @default.
- W2160257210 cites W2163707326 @default.
- W2160257210 cites W2167922729 @default.
- W2160257210 cites W2171934314 @default.
- W2160257210 cites W2268139906 @default.
- W2160257210 cites W2313020302 @default.
- W2160257210 cites W2333143411 @default.
- W2160257210 cites W2333322030 @default.
- W2160257210 cites W2333910906 @default.
- W2160257210 cites W2336208433 @default.
- W2160257210 cites W2341398312 @default.
- W2160257210 cites W2408956519 @default.
- W2160257210 cites W2409954446 @default.
- W2160257210 cites W2410885241 @default.
- W2160257210 cites W2735636272 @default.
- W2160257210 doi "https://doi.org/10.1016/s0895-7061(01)02074-x" @default.
- W2160257210 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11411770" @default.
- W2160257210 hasPublicationYear "2001" @default.
- W2160257210 type Work @default.
- W2160257210 sameAs 2160257210 @default.
- W2160257210 citedByCount "293" @default.
- W2160257210 countsByYear W21602572102012 @default.
- W2160257210 countsByYear W21602572102013 @default.
- W2160257210 countsByYear W21602572102014 @default.
- W2160257210 countsByYear W21602572102015 @default.
- W2160257210 countsByYear W21602572102016 @default.